Discovery of β-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV-Reference-Cited by-同舟云学术

Discovery of β-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV

Published:2009-08 Issue:15 Volume:19 Page:4201-4203
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Nordhoff Sonja,Cerezo-Gálvez Silvia,Deppe Holger,Hill Oliver,López-Canet Meritxell,Rummey Christian,Thiemann Meinolf,Matassa Victor G.,Edwards Paul J.,Feurer Achim

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference32 articles.

1. “The next big thing” in diabetes: clinical progress on DPP-IV inhibitors

2. Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of Type 2 diabetes

3. Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes

4. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides

5. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virtual Screening of Natural Products Database;Mini-Reviews in Medicinal Chemistry;2021-11-23

2. Recent Medicinal Chemistry Approach for the Development of Dipeptidyl Peptidase IV Inhibitors;Current Medicinal Chemistry;2021-06-10

3. Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening;Medicinal Research Reviews;2018-04-16

4. An Overview of Recent Dipeptidyl Peptidase-IV Inhibitors: Linking their Structure and Physico-Chemical Properties with SAR, Pharmacokinetics and Toxicity;Current Topics in Medicinal Chemistry;2015-08-21

5. Sixteen-Years of Clinically Relevant Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors for Treatment of Type-2 Diabetes: A Perspective;Current Medicinal Chemistry;2014-10-23